Page 9 - Carlos Buesa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ORYZON to Present New Clinical Data and Corporate Updates at Conferences in February and March Oryzon Genomics, S.A.February 10, 2021 GMT 2021 BIO CEO & Investor Digital Conference 15th International Conference on Alzheimer’s and Parkinson’s Diseases AD/PD 2021 H.C. Wainwright Global Life Sciences Conference BioCapital Europe 2021 33rd Annual ROTH Conference MADRID, Spain and CAMBRIDGE, Mass., Feb. 10, 2021 (GLOBE NEWSWIRE) Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announces that it will present new clinical data and attend several industry conferences in February and March, all in virtual format due to the Covid-19 pandemic.

United statesUnited kingdomComunidad autonoma de catalunaMichael ropackiCarlos buesaBiocapital europeTorsten hoffmannHc wainwright global life sciences conferenceEuropean life sciencesOncology partnering panelInternational conference on alzheimerInternational conferenceCapital europeAnnual european life sciencesDigital conferenceGlobal life sciences conference